4.04 USD
↗ 0.25 (6.60%)AT CLOSE (11:59 AM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $4.04. ZNTL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 26, 2026.